REACH is an independent pharmaceutical market research company specializing in rare and niche diseases. We are a values-driven team that cares deeply about each other and the partners and customers with whom we work. With decades of experience in pharmaceutical market research and life sciences consulting, our team aims to use all that we have learned to fill an important gap in the market – accessible market research solutions for rare and niche diseases. We work hard to use data and insights generation to tell the story of these disease markets to help life sciences companies make the most informed decisions about their path forward.
REACH is an independent pharmaceutical market research company specializing in rare and niche diseases. We are a values-driven team that cares deeply about our each other and the partners and customers with whom we work. With decades of experience in pharmaceutical market research and life sciences consulting, our team aims to use all that we have learned to fill an important gap in the market – accessible market research solutions for rare and niche diseases. We work hard to use data and insights generation to tell the story of these disease markets to help life sciences companies make the most informed decisions about their path forward.
OUR VALUES
OUR VALUES
WHY TEAMS LIKE PARTNERING WITH REACH
You get your A-team, every time
Highly experienced pharma market researchers, without big-agency overhead — strategic insights and thought partnership at better value.
Broad disease experience
192 diseases across 14 therapy areas over the last 5 years, including rare and oncology — expertise where complexity demands experience.
Access to syndicated market intelligence
Access our growing library of 50+ disease-specific market assessments to jumpstart understanding from day one.
Speed without
sacrifice
Our agile research model can deliver full commercial assessments in 3 to 5 weeks without cutting corners.
Transparent
pricing
No surprise fees — predictable costs make expanding scope simple and stress-free.
OUR VALUES
WHY TEAMS LIKE PARTNERING WITH REACH
You get your A-team, every time
Highly experienced pharma market researchers, without big-agency overhead — strategic insights and thought partnership at better value.
Broad disease experience
192 diseases across 14 therapy areas over the last 5 years, including rare and oncology — expertise where complexity demands experience.
Access to syndicated market intelligence
Access our growing library of 50+ disease-specific market assessments to jumpstart understanding from day one.
Speed without
sacrifice
Our agile research model can deliver full commercial assessments in 3 to 5 weeks without cutting corners.
Transparent
pricing
No surprise fees — predictable costs make expanding scope simple and stress-free.
MEET OUR SENIOR TEAM
Danielle Drayton, PhD
CEO and Founder
Melissa Curran
Senior Director of Product Management
Sarah Soucy
Senior Director of Market Research
Amanda Theocles
Senior Director of Business Operations